NCT01291732View on ClinicalTrials.gov

Single Rising Dose Study of BI 135585 XX in Health Asian Male Volunteers.

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

April 30, 2011

Conditions
Healthy
Interventions
DRUG

Matching placebo

single dose of matching placebo

DRUG

BI 135585 XX

single dose of low, medium or high dose of BI 135585 XX

Trial Locations (1)

Unknown

1283.5.82001 Boehringer Ingelheim Investigational Site, Seoul

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY